Market Cap 1.66B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 7,675,400
Avg Vol 6,274,652
Day's Range N/A - N/A
Shares Out 305.38M
Stochastic %K 90%
Beta 1.02
Analysts Strong Sell
Price Target $10.43

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
Stocktradesmoon
Stocktradesmoon May. 29 at 2:48 PM
$ABCL This may be the most significant weekly candle that the chart has printed since IPO. After spending years below the 200SMA, we are now knocking on the door of a potential secular uptrend. Very intrigued to see how we close out this weekly candle today and looking forward to whatever lies ahead. Long & Strong.🧘‍♂️
0 · Reply
bonecrack_benny
bonecrack_benny May. 29 at 2:37 PM
$ABCL Back to green
0 · Reply
bonecrack_benny
bonecrack_benny May. 29 at 2:29 PM
$ABCL ❤️
0 · Reply
tradersunion353
tradersunion353 May. 29 at 1:56 PM
$ABCL Becuase this Ugly stock is down - Now Demamp clown and his his friends will start cheerleading with adding and loading comments.
0 · Reply
tradersunion353
tradersunion353 May. 29 at 1:55 PM
$ABCL Overhyped underperforming Junk is droipping as if this POS is up by300% in recent years and months
0 · Reply
Buying_Low_Selling_High
Buying_Low_Selling_High May. 29 at 1:43 PM
$ABCL As expected. Should be above $5.64 by end of the day.
1 · Reply
PLTRLONGDONG
PLTRLONGDONG May. 29 at 1:36 PM
$ABCL tap 5.50 and go
0 · Reply
Reactor_Rebel
Reactor_Rebel May. 29 at 11:37 AM
$ABCL everybody wants the life-changing trade, but nobody wants the lonely part where you look early, sound crazy, and check the chart wondering if you’re the only one seeing it
0 · Reply
BinaryLogic
BinaryLogic May. 29 at 8:43 AM
0 · Reply
Stocktradesmoon
Stocktradesmoon May. 29 at 5:07 AM
$ABCL $ABCL crew this is your $PLTR MOMENT. He knows. $20 by EoY or right after Q3 results (possibly even by end of Summer) Stage 1 math What a clean Phase 2 hit in Q3 is actually worth: Phase 3 Odds of success: 55-65% Risk-adj peak sales( 60% of half TAM): $3B × 60% = $1.8B Peak multiple 4.5x = $8.1B PV @ 12% over ~6yrs ≈ $4.1B ABCL635 alone: ~$4-4.5B EV ( 3X from current price) Other buckets: Cash + gov't funding: ~$0.65B Royalty book (bam residual + others): ~$0.3-0.4B Pipeline (575/688/386 + 20 discovery): ~$0.3-0.5B Platform (Trianni/Celium): ~$0.3-0.5B Non-635 total: ~$1.6-2.1B Stage 1 EV: ~$5.6-6.6B ÷ 305M shares = ~$18-22/share = 3.5-4x from $5.24. The biggest single re-rating on the entire ABCL635 path is right here at the Q3 readout. Phase 3 approval. the US TAM for 635 was estimated at $6BN. this is a $50+ stock in 18-24mths
0 · Reply
Latest News on ABCL
AbCellera price target raised to $8 from $7 at Stifel

2026-05-12T10:58:11.000Z - 17 days ago

AbCellera price target raised to $8 from $7 at Stifel


AbCellera Biologics Q1 Earnings Call Highlights

May 11, 2026, 7:08 PM EDT - 17 days ago

AbCellera Biologics Q1 Earnings Call Highlights


AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 17 days ago

AbCellera Biologics Earnings Call Transcript: Q1 2026


AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 17 days ago

AbCellera Biologics Earnings release: Q1 2026


AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 17 days ago

AbCellera Biologics Quarterly report: Q1 2026


AbCellera Biologics Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 17 days ago

AbCellera Biologics Slides: Q1 2026


AbCellera initiated with an Overweight at Cantor Fitzgerald

2026-05-05T10:36:31.000Z - 24 days ago

AbCellera initiated with an Overweight at Cantor Fitzgerald


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 weeks ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 weeks ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera initiated with a Buy at JonesResearch

2026-04-09T20:10:26.000Z - 7 weeks ago

AbCellera initiated with a Buy at JonesResearch


AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025


AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Annual report: Q4 2025


AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Earnings release: Q4 2025


AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Slides: Q4 2025


AbCellera reports FY25 EPS (49c) vs. (55c) last year

2026-02-24T21:15:21.000Z - 3 months ago

AbCellera reports FY25 EPS (49c) vs. (55c) last year


AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 3 months ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Biologics Slides: Corporate presentation

Jan 14, 2026, 7:00 AM EST - 4 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 7 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025


AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

AbCellera Biologics Quarterly report: Q3 2025


AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

AbCellera Biologics Earnings release: Q3 2025


AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

AbCellera Biologics Slides: Q3 2025


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 7 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera appoints Sarah Noonberg as Chief Medical Officer

2025-09-10T13:20:54.000Z - 9 months ago

AbCellera appoints Sarah Noonberg as Chief Medical Officer

MGX


AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 9 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer


AbCellera doses first participants in Phase 1 trial of ABCL575

2025-08-27T13:20:26.000Z - 9 months ago

AbCellera doses first participants in Phase 1 trial of ABCL575


AbCellera price target raised to $7 from $5 at BMO Capital

2025-08-08T13:26:29.000Z - 10 months ago

AbCellera price target raised to $7 from $5 at BMO Capital


AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Earnings Call Transcript: Q2 2025


AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Quarterly report: Q2 2025


AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Earnings release: Q2 2025


AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Slides: Q2 2025


AbCellera Biologics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 10 months ago

AbCellera Biologics Slides: Corporate Presentation


AbCellera assumed with an Outperform at Leerink

2025-07-07T10:40:33.000Z - 11 months ago

AbCellera assumed with an Outperform at Leerink


AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025


AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025


AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025


AbCellera Biologics Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024


AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024


AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024


AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025


AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024


AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024


AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024


AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q2 2024


AbCellera Biologics Quarterly report: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q2 2024


AbCellera Biologics Earnings release: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q2 2024


AbCellera Biologics Slides: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q2 2024


AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 1 year ago

AbCellera Reports Q2 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2024


AbCellera Biologics Quarterly report: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q1 2024


AbCellera Biologics Earnings release: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q1 2024


AbCellera Biologics Slides: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q1 2024


AbCellera Reports Q1 2024 Business Results

May 7, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q1 2024 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

AbCellera Biologics Proxy statement: Proxy Filing


Stocktradesmoon
Stocktradesmoon May. 29 at 2:48 PM
$ABCL This may be the most significant weekly candle that the chart has printed since IPO. After spending years below the 200SMA, we are now knocking on the door of a potential secular uptrend. Very intrigued to see how we close out this weekly candle today and looking forward to whatever lies ahead. Long & Strong.🧘‍♂️
0 · Reply
bonecrack_benny
bonecrack_benny May. 29 at 2:37 PM
$ABCL Back to green
0 · Reply
bonecrack_benny
bonecrack_benny May. 29 at 2:29 PM
$ABCL ❤️
0 · Reply
tradersunion353
tradersunion353 May. 29 at 1:56 PM
$ABCL Becuase this Ugly stock is down - Now Demamp clown and his his friends will start cheerleading with adding and loading comments.
0 · Reply
tradersunion353
tradersunion353 May. 29 at 1:55 PM
$ABCL Overhyped underperforming Junk is droipping as if this POS is up by300% in recent years and months
0 · Reply
Buying_Low_Selling_High
Buying_Low_Selling_High May. 29 at 1:43 PM
$ABCL As expected. Should be above $5.64 by end of the day.
1 · Reply
PLTRLONGDONG
PLTRLONGDONG May. 29 at 1:36 PM
$ABCL tap 5.50 and go
0 · Reply
Reactor_Rebel
Reactor_Rebel May. 29 at 11:37 AM
$ABCL everybody wants the life-changing trade, but nobody wants the lonely part where you look early, sound crazy, and check the chart wondering if you’re the only one seeing it
0 · Reply
BinaryLogic
BinaryLogic May. 29 at 8:43 AM
0 · Reply
Stocktradesmoon
Stocktradesmoon May. 29 at 5:07 AM
$ABCL $ABCL crew this is your $PLTR MOMENT. He knows. $20 by EoY or right after Q3 results (possibly even by end of Summer) Stage 1 math What a clean Phase 2 hit in Q3 is actually worth: Phase 3 Odds of success: 55-65% Risk-adj peak sales( 60% of half TAM): $3B × 60% = $1.8B Peak multiple 4.5x = $8.1B PV @ 12% over ~6yrs ≈ $4.1B ABCL635 alone: ~$4-4.5B EV ( 3X from current price) Other buckets: Cash + gov't funding: ~$0.65B Royalty book (bam residual + others): ~$0.3-0.4B Pipeline (575/688/386 + 20 discovery): ~$0.3-0.5B Platform (Trianni/Celium): ~$0.3-0.5B Non-635 total: ~$1.6-2.1B Stage 1 EV: ~$5.6-6.6B ÷ 305M shares = ~$18-22/share = 3.5-4x from $5.24. The biggest single re-rating on the entire ABCL635 path is right here at the Q3 readout. Phase 3 approval. the US TAM for 635 was estimated at $6BN. this is a $50+ stock in 18-24mths
0 · Reply
TradeWinner
TradeWinner May. 29 at 2:15 AM
$ABCL 🔥🔥🔥🔥nuff said
0 · Reply
Reactor_Rebel
Reactor_Rebel May. 29 at 1:55 AM
$ABCL will hit $6+ tomorrow, do what you will with this information
0 · Reply
Stocktradesmoon
Stocktradesmoon May. 29 at 1:52 AM
$ABCL For those of you that are new, Phase 2 readouts are around the corner for ABCL635. Below is why I believe we will see positive results in Q3. TLDR - direct MnPO activation is not required to achieve reduction in hot flashes
0 · Reply
snowPOW
snowPOW May. 29 at 1:21 AM
$ABCL great day!
0 · Reply
Stocktradesmoon
Stocktradesmoon May. 29 at 12:22 AM
$ABCL $ABCL has a documented history of directly isolating anti-Ebola antibodies. In 2016, under DARPA's ADEPT-PROTECT program, the company successfully discovered hundreds of human anti-Ebola antibodies from a single patient sample in less than a week. ​This early success was instrumental in DARPA awarding AbCellera a $30 million contract in 2018 to lead the Pandemic Prevention Platform (P3), which funded the development of their rapid-response technology. ​With the current Ebola outbreak in Central Africa requiring urgent medical countermeasures, AbCellera's proven framework in this exact pathogen space could make them a critical asset for global health agencies mobilizing a response.
0 · Reply
Stocktradesmoon
Stocktradesmoon May. 28 at 11:57 PM
0 · Reply
UncleTomFlorida
UncleTomFlorida May. 28 at 11:55 PM
$ABCL A.I. analysis of Abcellera https://probabli.xyz/stock/ABCL
0 · Reply
UncleTomFlorida
UncleTomFlorida May. 28 at 11:52 PM
$ABCL My opinion and belief is that $IBRX & $ABCL together have the inherent potential to dominate preventative & curative medicine within the next ten years. Big Pharma can’t buy them or destroy them. It used to be able to rent their BioTech. That door is closing fast.
0 · Reply
UncleTomFlorida
UncleTomFlorida May. 28 at 11:47 PM
$ABCL Prescott’s one pager on $ABCL. $ABCL is my third primary investment, after $NVDA and $PLTR. https://x.com/JackPrescottX/status/2060140313105039747?s=20
0 · Reply
Stocktradesmoon
Stocktradesmoon May. 28 at 10:21 PM
$ABCL $ABCL One week from today, on June 4 at 11:40am ET, Jefferies will hold a conference in New York. If anyone is there, I'd love to get the vibe of the talk with AbCellera. A tidbit: Jefferies is the bank that helped Baker Bros accumulate about 2.7m shares and sold them those deep in the money strikes. Those shares will transfer over to Baker Bros on June 12, about a week after the conference is over. I wouldn't read into that timing too much but just interesting. You can register to listen/watch virtually here: https://event.summitcast.com/view/NgCqua4VVQjq9ibVWHVWca/Xq98ksDDdKZr3LbVeerngv I'll be listening for any progress on status of abcl635 phase 2 or additional insights into phase 1 data. If we're lucky, we'll also get announcement of the next molecule moving into IND enabling studies. Good luck to all the longs!
0 · Reply
Stocktradesmoon
Stocktradesmoon May. 28 at 9:32 PM
$ABCL On top of everything that I’ve mentioned already Ebola will send $ABCL to the moon South Africa and the world need $ABCL and its antibodies
1 · Reply
Beat_market_loser
Beat_market_loser May. 28 at 8:08 PM
$ABCL only the mar is LAES’ destination
0 · Reply